MERS Coronaviruses in Dromedary Camels, Egypt
Daniel K.W. Chu
1, Leo L.M. Poon
1, Mokhtar M. Gomaa, Mahmoud M. Shehata, Ranawaka A.P.M. Perera, Dina Abu Zeid, Amira S. El Rifay, Lewis Y. Siu, Yi Guan, Richard J. Webby, Mohamed A. Ali, Malik Peiris

, and Ghazi Kayali
Author affiliations: The University of Hong Kong, Hong Kong, China (D.K.W. Chu, L.L.M. Poon, R.A.P.M. Perera, Y. Guan, M. Peiris); National Research Centre, Giza, Egypt (M.M. Gomaa, M.M. Shehata, D.A. Zeid, A.S. El Rifay, M.A. Ali); HKU-Pasteur Research Pole, Hong Kong (L.Y. Siu); St. Jude Children’s Research Hospital, Memphis, Tennessee, USA (R.J. Webby, G. Kayali)
Main Article
Table 2
Percentage identity between ORFs of dromedary camel MERS-CoV (NRCE-HKU205) and human MERS-CoV (EMC/2012) at the nucleotide and amino acid levels*
ORF |
% Identity to HCoV-EMC/2012
|
Nucleotide |
Amino acid |
ORF1a |
99.5 |
99.2 |
ORF1b |
99.5 |
99.7 |
S |
99.2 |
98.9 |
ORF3 |
99.0 |
98.0 |
ORF4a |
99.0 |
100 |
ORF4b |
99.4 |
99.1 |
ORF5 |
99.4 |
98.6 |
E |
100 |
100 |
M |
100 |
100 |
N |
99.4 |
99.2 |
ORF8b |
99.1 |
98.2 |
Main Article
Page created: May 16, 2014
Page updated: May 16, 2014
Page reviewed: May 16, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.